Table 3. Parameters of efficacy of Proclarix score (threshold 10%) to detect clinically significant prostate cancer in overall study population.
| Parameter | Value |
|---|---|
| Sensitivity | 224/230 (97.4) |
| Specificity | 90/337 (26.7) |
| Negative predictive value | 90/96 (93.8) |
| Positive predictive value | 224/471 (47.6) |
| Accuracy | 314/567 (55.4) |
| Avoided magnetic resonance imaging | 96/567 (16.9) |
| Undetected clinically significant prostate cancer | 6/230 (2.6) |
| Odds ratio (95% confidence interval) | 13.603 (5.838–31.698) |
| p-value | <0.001 |
Values are presented as number (%).